Atrás
75
78
Rango del Día
$4.35
$5.22
Rango de 52 Semanas
$3.43
$5.22
Volumen
1
Promedio 50D / 200D
$5.22
/
$4.66
Cierre Anterior
$5.22
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 2.9 | 0.4 |
| P/B | 0.4 | 2.9 |
| ROE % | 14.8 | 3.7 |
| Net Margin % | 17.5 | 3.9 |
| Rev Growth 5Y % | 2.9 | 10.0 |
| D/E | 0.3 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$2.66
$2.49 – $2.76
|
13 B | 1 |
| FY2026 |
$2.44
$2.28 – $2.54
|
12 B | 1 |
Puntos Clave
Revenue grew 2.94% annually over 5 years — modest growth
ROE of 14.77% — decent returns on equity
Net margin of 17.45% shows strong profitability
Debt/Equity of 0.28 — conservative balance sheet
Generating 2.41B in free cash flow
P/E of 2.94 — trading at a low valuation
Crecimiento
Revenue Growth (5Y)
2.94%
Revenue (1Y)-4.97%
Earnings (1Y)5.50%
FCF Growth (3Y)14.65%
Calidad
Return on Equity
14.77%
ROIC11.99%
Net Margin17.45%
Op. Margin24.08%
Seguridad
Debt / Equity
0.28
Current Ratio2.15
Interest Coverage32.10
Valoración
P/E Ratio
2.94
P/B Ratio0.44
EV/EBITDA-0.29
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.97% | Revenue Growth (3Y) | -3.29% |
| Earnings Growth (1Y) | 5.50% | Earnings Growth (3Y) | 3.90% |
| Revenue Growth (5Y) | 2.94% | Earnings Growth (5Y) | 4.70% |
| Profitability | |||
| Revenue (TTM) | 11.81B | Net Income (TTM) | 2.06B |
| ROE | 14.77% | ROA | 8.43% |
| Gross Margin | 65.45% | Operating Margin | 24.08% |
| Net Margin | 17.45% | Free Cash Flow (TTM) | 2.41B |
| ROIC | 11.99% | FCF Growth (3Y) | 14.65% |
| Safety | |||
| Debt / Equity | 0.28 | Current Ratio | 2.15 |
| Interest Coverage | 32.10 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 2.94 | P/B Ratio | 0.44 |
| P/S Ratio | 0.51 | PEG Ratio | 1.68 |
| EV/EBITDA | -0.29 | Dividend Yield | 0.06% |
| Market Cap | 6.06B | Enterprise Value | -830.33M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 11.81B | 12.43B | 12.63B | 12.06B | 10.52B |
| Net Income | 2.06B | 1.95B | 1.91B | 1.78B | 1.71B |
| EPS (Diluted) | 2.24 | 2.10 | 2.04 | 1.90 | 1.83 |
| Gross Profit | 7.73B | 7.66B | 8.17B | 7.81B | 6.85B |
| Operating Income | 2.84B | 2.42B | 2.35B | 2.27B | 2.50B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 24.46B | 25.04B | 24.86B | 22.37B | 20.59B |
| Total Liabilities | 9.55B | 10.28B | 9.93B | 8.06B | 6.95B |
| Shareholders' Equity | 13.86B | 14.04B | 13.88B | 13.00B | 12.11B |
| Total Debt | 3.93B | 3.48B | 3.62B | 2.69B | 1.93B |
| Cash & Equivalents | 10.83B | 11.33B | 10.41B | 9.15B | 9.95B |
| Current Assets | 16.42B | 17.27B | 16.99B | 14.67B | 14.63B |
| Current Liabilities | 7.63B | 8.09B | 7.40B | 6.93B | 6.08B |
Puntuaciones de Estrategias
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#26 of 820
#9 of 708
Actividad Reciente
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró
Defensive Investing (Benjamin Graham)
Mar 24, 2026